FreedomEDGE® + RYSTIGGO®
Generalized Myasthenia Gravis
ClearedCommercial
Key Facts
About KORU Medical Systems
KORU Medical Systems is a mission-driven company commercializing subcutaneous infusion systems to enable home-based care for chronic therapies, primarily in immunology. A key recent achievement is the FDA clearance of its FreedomEDGE® pump for the administration of UCB's RYSTIGGO® (rozanolixizumab-noli) in generalized myasthenia gravis, validating its strategy of pursuing drug-specific indications. The company leverages a focused commercial team and a 510(k)-cleared platform to target the large and growing market for subcutaneous immunoglobulin (SCIg) and other biologics, aiming to reduce healthcare burdens and improve patient freedom.
View full company profileTherapeutic Areas
Other Generalized Myasthenia Gravis Drugs
| Drug | Company | Phase |
|---|---|---|
| Rozanolixizumab | Astellas Pharma | Approved |
| Nipocalimab | Johnson & Johnson | Phase 3 |
| VYVGART® Hytrulo (with Argenx) | Halozyme Therapeutics | Approved |